Moteur de recherche d’entreprises européennes
Financement de l’UE (3 890 065 €) : Pousser la prochaine génération de chercheurs sur l’autophagie vers la traduction Hor10/10/2017 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Pousser la prochaine génération de chercheurs sur l’autophagie vers la traduction
The manipulation of autophagy has an enormous therapeutic potential to revolutionize the way we currently treat cancers, neurodegenerative disorders, inflammatory and infectious diseases. Despite the great promises made by pioneering medical studies, the still limited applied research on autophagy has hampered the translation of fundamental knowledge into clinical-grade products and improved healthcare. Applied autophagy research is essential to understand the roles of autophagy in the different physiological and pathological situations, to generate (disease) models and develop biomarkers and assays to assess its progress. The goal of the ETN Driving next generation autophagy researchers towards translation (DRIVE) is to train young scientists to fill this gap. DRIVE will equip its ESRs with an unique combination of knowledge and experimental expertise that are brought together in this consortium by the different partners. The realization of their projects in applied autophagy research will benefit of an exceptional interdisciplinary platform integrating cell biology, biochemistry, molecular biology, genetics, chemistry and “omics” approaches. In addition, DRIVE ESRs will acquire competencies to exploit the results for the development of products and techniques of commercial value. These ESRs will also be trained in disseminating results and knowledge through modern channels of communication.
| Centre National de la Recherche Scientifique CNRS | ? |
| Academisch Ziekenhuis Groningen | 510 749 € |
| Adjuvatis | 262 876 € |
| Agencia Estatal Consejo Superior de Investigaciones Cientificas | 495 746 € |
| Anaxomics Biotech SL | 247 873 € |
| Eberhard Karls Universitaet Tuebingen | 249 216 € |
| Fraunhofer Gesellschaft ZUR Forderung DER Angewandten Forschung e. V. | 249 216 € |
| Helsingin Yliopisto | 0,00 € |
| Institute of Cancer Research: the Royal Cancer Hospital LBG | 273 288 € |
| Institut National de la Sante et de la Recherche Medicale | 262 876 € |
| King's College London | 273 288 € |
| QPS Netherlands B.V. | 0,00 € |
| Turun Yliopisto | 269 145 € |
| Universitaetsklinikum Freiburg | 249 216 € |
| Universitetet I Oslo | 286 275 € |
| Weizmann Institute OF Science | 260 301 € |
https://cordis.europa.eu/project/id/765912
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Centre National de la Recherche Scientifique, Paris.